tm logo
SURGE THERAPEUTICS
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 08 Oct 2024

Last Applicant/ Owned by

B712

BROOKLINE

MA

02446

Serial Number

97042717 filed on 23rd Sep 2021

Registration Number

N/A

Correspondent Address

Sara M. Bauer

Sara M. Bauer Womble Bond Dickinson (US) LLP

Independence Wharf

Boston, MA 02110

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SURGE THERAPEUTICS

Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing medical research and scientific research information in the fields of oncology and immunotherapy via a website Artificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy Hydroge Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing medical research and scientific research information in the fields of oncology and immunotherapy via a website


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [010]
Medical Instrument Products


Artificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Hydrogel for medical purposes; Natural biomaterial for delivery of immunotherapy; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; Natural intraoperative biomaterial for delivery of immunotherapy


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97042717

Mark Type

No Service Mark

Attorney Docket Number

No 120292.00026

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Oct 2024SOU EXTENSION 1 GRANTED
08th Oct 2024SOU EXTENSION 1 FILED
08th Oct 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08th Oct 2024SOU TEAS EXTENSION RECEIVED
23rd Apr 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27th Feb 2024PUBLISHED FOR OPPOSITION
07th Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07th Feb 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24th Jan 2024APPROVED FOR PUB - PRINCIPAL REGISTER